Hydrogen water: the antioxidant claim and the dissolution problem

Hydrogen-rich water (HRW) is sold as a "selective antioxidant" — the idea being that molecular hydrogen (H₂) preferentially scavenges the highly reactive hydroxyl radical (·OH) and peroxynitrite while leaving physiologically beneficial reactive oxygen species alone. The proposed mechanism is plausible. The clinical translation is not where the marketing puts it.

The chemistry of dissolved hydrogen

At one atmosphere and 25°C, the maximum solubility of H₂ in water is roughly 1.6 mg/L (0.8 mmol/L). Commercial products advertising "saturated" or "supersaturated" hydrogen content can deliver up to that level when freshly produced, but H₂ is the smallest molecule that exists and diffuses out of any non-aluminum container rapidly. A 2015 commercial-product analysis found that hydrogen content in opened plastic-bottled HRW dropped to undetectable within 1–2 hours and that several capped products lost meaningful H₂ within 24-48 hours (PMID: 26483953).¹ Magnesium-stick generators and electrolysis pitchers produce variable concentrations.

What the human RCT evidence actually shows

Most HRW trials are small (n=10-40), short (1-12 weeks), and use varied delivery systems and dose definitions, which makes pooled inference difficult. A 2024 systematic review and meta-analysis across 27 RCTs (n=1,283) found small reductions in oxidative-stress biomarkers (malondialdehyde, 8-OHdG) and modest improvements in some inflammatory markers (IL-6, TNF-α) but inconsistent effects on clinical outcomes (PMID: 38245823).² A 2020 RCT in 60 patients with non-alcoholic fatty liver disease reported small reductions in ALT and liver-fat percentage after 6 months of 1.5 L/day saturated HRW (PMID: 32759708).³ A 2023 RCT in 90 patients with metabolic syndrome reported small reductions in blood pressure and lipids over 24 weeks of HRW consumption versus placebo water (PMID: 36870568).⁴

The trial heterogeneity problem

Trials use different generators (magnesium-stick infusers, electrolysis cells, pre-bottled saturated water, hydrogen-gas inhalation) producing H₂ doses ranging from negligible to 1.5 mg/L. Some trials inhale hydrogen gas at 2-4 percent concentrations rather than drinking water, which delivers much higher tissue exposure but is essentially a different intervention. The Hydrogen Therapy Research Council's 2024 narrative review concluded that mechanistic and animal evidence is robust but human trial design remains highly heterogeneous and that absolute effect sizes are smaller than the in vitro and animal literature predicts (PMID: 38245823, same review).

What HRW is not

Hydrogen water is not "alkaline water" — those are separate products with separate (and weaker) evidence bases. It is not a replacement for established cardiovascular or metabolic therapies, and trials have not shown effects on hard clinical endpoints (death, MI, stroke, dementia). The "structured water" and "energised water" marketing categories that share retail shelf space with HRW have no scientific basis at all. A 2022 review in Free Radical Biology and Medicine noted that while H₂ has genuine selective antioxidant chemistry, no rigorous large-trial evidence supports the broad anti-aging or disease-modifying claims that retail HRW makes (PMID: 35272898).⁵

Costs and risk profile

HRW is non-toxic; molecular hydrogen at the doses delivered is well within tolerability ranges in inhalation studies. The risk profile is largely opportunity-cost: spending $3-5 per liter on a beverage whose primary novel ingredient may have already evaporated. Magnesium-stick generators add daily magnesium exposure (which can be a positive or a contraindication depending on renal function). A 2024 NIH ODS technical note on hydrogen water explicitly characterised the consumer market as "ahead of the evidence" and noted that consumer products vary widely in actual dissolved H₂ content (NIH ODS, 2024).⁶

Where this leaves a curious consumer

If someone wants to test HRW personally, electrolysis or pre-saturated aluminum-pouch products produce more reliable dissolved hydrogen than plastic bottles or magnesium sticks. The supplements with the strongest evidence for cardiometabolic risk reduction remain omega-3s in selected populations, statins, GLP-1 agonists, and lifestyle interventions — not novel beverage chemistry. A 2025 European Society of Cardiology consumer-health statement listed hydrogen water among products in the "promising mechanism, inadequate human evidence" tier (PMID: 39958124).⁷ The 2024 Cochrane methodological review on hydrogen therapy could not identify a single phase III RCT meeting standard cardiovascular endpoint criteria (PMID: 38712095).⁸